Table 2 Linear regression analysis of laboratories as well as echocardiographic and electrocardiographic parameters with moderate and high coffee consumption.
Coffee consumption | ||||
|---|---|---|---|---|
Moderate (3–4 cups/day) | High (> 4 cups/day) | |||
beta (95% CI) | p-value | beta (95% CI) | p-value | |
Laboratory | ||||
Total cholesterol, mg/dl | 1.09 (− 1.14, 3.33) | 0.337 | 4.78 (1.56, 8.0) | 0.004 |
LDL, mg/dl | 1.63 (− 0.42, 3.68) | 0.119 | 5.92 (2.95, 8.89) | < 0.001 |
HDL, mg/dl | 0.57 (− 0.32, 1.46) | 0.207 | − 0.83 (− 2.11, 0.45) | 0.206 |
NT-proBNP, ng/l | − 0.06 (− 0.11, − 0.02) | 0.005 | − 0.09 (− 0.15, − 0.02) | 0.013 |
Vital signs | ||||
Heart rate, bpm | − 0.62 (− 1.24, 0.01) | 0.052 | − 0.02 (− 0.92, 0.89) | 0.969 |
Systolic blood pressure, mmHg | − 1.91 (− 3.04, − 0.78 | 0.001 | − 3.06 (− 4.69, − 1.44) | < 0.001 |
Diastolic blood pressure, mmHg | − 1.05 {− 1.67, − 0.43} | 0.001 | − 1.85 {− 2.74, − 0.96} | < 0.001 |
Electrocardiography | ||||
PQ interval, ms | 0.42 (− 1.12, 1.96) | 0.592 | − 0.68 (− 2.89, 1.53) | 0.548 |
QRS interval, ms | 0.80 (0.01, 1.59) | 0.048 | − 0.43 (− 1.58, 0.71) | 0.458 |
QTc interval, ms | − 3.18 (− 6.41, 0.05) | 0.053 | − 3.81 (− 8.49, 0.88) | 0.111 |
Echocardiography | ||||
LVEF, % | 0.20 (− 0.12, 0.53) | 0.238 | 0.12 (− 0.37, 0.60) | 0.634 |
LV mass index, g/m2 | − 0.06 (− 1.30, 1.17) | 0.919 | 0.13 (− 1.65, 1.90) | 0.887 |
E/e' mean ratio | − 0.10 (− 0.23, 0.03) | 0.138 | − 0.09 (− 0.27, 0.10) | 0.347 |
TR Vmax, m/s | − 0.01 (− 0.03, 0.02) | 0.623 | − 0.01 (− 0.06, 0.03) | 0.527 |
TAPSE, mm | 0.16 (− 0.15, 0.47 | 0.322 | 0.27 (− 0.18, 0.71) | 0.239 |
LASV, ml | − 0.06 (− 1.30, 1.17) | 0.919 | 0.13 (− 1.65, 1.90) | 0.887 |